An ad hoc committted reviewed proposals for research on statistical methodologies for assessing variables in eyewitness performance. Its report describes the development of the request for proposals, ...
A model assessing how variable timing of outcome assessments impacts progression-free survival (PFS)
Suberoylanilide hydroxamic acid (vorinostat) post chemotherapy in hormone refractory prostate cancer (HRPC) patients (pts): A phase II trial by the Prostate Cancer Clinical Trials Consortium (NCI 6862 ...
A prerequisite for receiving HER2-targeted therapy is the identification of HER2-overexpression either in the primary tumor or in metastatic lesions. Reliable, high-quality HER2 testing for clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results